'J&J Is Leaning Toward Spinning Out Its Hips-And-Knees Business' - The Wall Street Journal

Johnson & Johnson (JNJ) is considering a spin-off of its hips and knees business, which is part of its orthopedics division. This strategic move is aimed at streamlining operations and focusing on its core pharmaceutical and consumer health segments. The decision reflects ongoing efforts to enhance shareholder value and adapt to market demands.